We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.72B
1-Year Est. Return 25.63%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+25.63%
3 Year Est. Return
+82.02%
5 Year Est. Return
+99.95%
10 Year Est. Return
+300.08%
AUM
$1.35B
AUM Growth
+$165M
Cap. Flow
+$51.1M
Cap. Flow %
3.78%
Top 10 Hldgs %
32.11%
Holding
496
New
62
Increased
207
Reduced
116
Closed
29

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.65%
2 Technology 19.66%
3 Financials 11.38%
4 Consumer Discretionary 7.43%
5 Healthcare 7.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LHX icon
76
L3Harris
LHX
$46B
$4.87M 0.36%
19,417
+521
+3% +$120K
ELV icon
77
Elevance Health
ELV
$89.1B
$4.83M 0.36%
+12,421
New +$5M
EOG icon
78
EOG Resources
EOG
$75.7B
$4.83M 0.36%
40,356
-12,044
-23% -$1.38M
BDX icon
79
Becton Dickinson
BDX
$49.3B
$4.54M 0.34%
26,375
-1,515
-5% -$278K
IDXX icon
80
Idexx Laboratories
IDXX
$40.3B
$4.34M 0.32%
8,094
+401
+5% +$192K
VRTX icon
81
Vertex Pharmaceuticals
VRTX
$129B
$4.2M 0.31%
9,444
+318
+3% +$147K
IEFA icon
82
iShares Core MSCI EAFE ETF
IEFA
$192B
$3.91M 0.29%
46,803
+6,426
+16% +$510K
LAMR icon
83
Lamar Advertising Co
LAMR
$14.9B
$3.51M 0.26%
+28,956
New +$3.36M
DGRO icon
84
iShares Core Dividend Growth ETF
DGRO
$42.4B
$3.5M 0.26%
54,708
+3,791
+7% +$231K
RTX icon
85
RTX Corp
RTX
$261B
$3.45M 0.26%
23,636
-1,893
-7% -$252K
AMAT icon
86
Applied Materials
AMAT
$353B
$3.19M 0.24%
17,436
-193
-1% -$30.6K
JNJ icon
87
Johnson & Johnson
JNJ
$651B
$2.97M 0.22%
19,450
-3,696
-16% -$568K
VEU icon
88
Vanguard FTSE All-World ex-US ETF
VEU
$69.2B
$2.97M 0.22%
44,131
+2,965
+7% +$188K
ALNT icon
89
Allient
ALNT
$1.71B
$2.93M 0.22%
80,631
-19,375
-19% -$539K
VYMI icon
90
Vanguard International High Dividend Yield ETF
VYMI
$21.4B
$2.85M 0.21%
35,528
+4,753
+15% +$364K
CTVA icon
91
Corteva
CTVA
$53.7B
$2.75M 0.2%
36,926
-605
-2% -$40.3K
MU icon
92
Micron Technology
MU
$1.15T
$2.56M 0.19%
20,748
-61,708
-75% -$5.76M
OEF icon
93
iShares S&P 100 ETF
OEF
$20.3B
$2.54M 0.19%
8,359
+4
+0% +$1.11K
VGSH icon
94
Vanguard Short-Term Treasury ETF
VGSH
$34.5B
$2.34M 0.17%
39,801
-148,774
-79% -$8.71M
PBJ icon
95
Invesco Food & Beverage ETF
PBJ
$88.9M
$2.32M 0.17%
49,099
+2,167
+5% +$102K
IQLT icon
96
iShares MSCI Intl Quality Factor ETF
IQLT
$13.8B
$2.3M 0.17%
53,184
+1,734
+3% +$72K
STZ icon
97
Constellation Brands
STZ
$20.3B
$2.29M 0.17%
14,061
-2,058
-13% -$369K
SCHB icon
98
Schwab US Broad Market ETF
SCHB
$44.4B
$2.19M 0.16%
91,866
+4,176
+5% +$92K
BRK.A icon
99
Berkshire Hathaway Class A
BRK.A
$1.09T
$2.19M 0.16%
3
COR icon
100
Cencora
COR
$58.9B
$1.92M 0.14%
6,390
-13,050
-67% -$3.76M

Similar funds

Howe & Rusling's Q2 2025 Portfolio in Review

As of Q2 2025, Howe & Rusling held 496 positions worth $1.35B, up 14% from $1.19B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Howe & Rusling deployed $51.1M of net new capital in Q2 2025, opening 62 new positions and adding to 207 existing holdings. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 146,598 shares worth $8.77M.

By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 30% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $8.71M trimmed.

  • Howe & Rusling's largest Q2 2025 buy was Vanguard Intermediate-Term Treasury ETF: 146,598 shares worth $8.77M.
  • Howe & Rusling added most to NextEra Energy in Q2 2025, an estimated $7.96M increase.
  • Howe & Rusling's biggest Q2 2025 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $8.71M.
  • Howe & Rusling fully exited BioMarin Pharmaceuticals in Q2 2025, selling an estimated $2.88M.
  • Howe & Rusling's ten largest holdings make up 32% of its $1.35B portfolio in Q2 2025.
  • Howe & Rusling opened 62 new positions and closed 29 in Q2 2025.
  • Howe & Rusling's portfolio value rose 14% quarter-over-quarter to $1.35B.

Based on Howe & Rusling's 13F filing for Q2 2025, filed 12 Aug 2025.